Journey Medical (DERM) Total Liabilities (2020 - 2026)

Journey Medical has reported Total Liabilities for 7 years, with the latest figure at $60.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 4.29% year-over-year to $60.7 million; the trailing twelve-month figure through Mar 2026 stood at $60.7 million (down 4.29% YoY), and the FY2025 full-year result was $62.7 million, up 4.26% from the prior year.
• Total Liabilities for Q1 2026 stood at $60.7 million, down from $62.7 million in the prior quarter.
• The five-year high for Total Liabilities was $88.4 million in Q1 2023, with the low at $48.5 million in Q3 2023.
• Historically, Total Liabilities has averaged $65.9 million across 5 years, with a median of $61.9 million in 2025.
• Annual changes were most pronounced in 2022 — Total Liabilities jumped 9836.99% — and 2023, when it tumbled 40.77%.
• Journey Medical's Total Liabilities stood at $88.2 million in 2022, then sank by 35.93% to $56.5 million in 2023, then rose by 6.5% to $60.2 million in 2024, then rose by 4.26% to $62.7 million in 2025, then declined by 3.24% to $60.7 million in 2026.
• The last three Total Liabilities figures came in at $60.7 million (Q1 2026), $62.7 million (Q4 2025), and $59.3 million (Q3 2025), per Business Quant data.